Case study of a patient with cervical cancer on postoperative day 1 after total hysterectomy and pelvic and para-aortic lymphadenectomy
DOI:
https://doi.org/10.12775/JEHS.2026.88.69350Keywords
cervical cancer, nursing care, hysterectomy, prevention, psychosocial supportAbstract
Cervical cancer remains one of the most common malignant neoplasms of the female reproductive system and constitutes a significant global health problem among women. The key etiological factor is persistent infection with oncogenic types of the Human papillomavirus (HPV), particularly types 16 and 18. Effective primary prevention (HPV vaccination) and secondary prevention (screening tests, including cytology and HPV testing) enable early detection of precancerous lesions and significantly reduce morbidity and mortality. Despite well-developed preventive programs, diagnoses at advanced stages are still observed. The treatment of cervical cancer is complex and burdensome, involving surgical methods (e.g., hysterectomy), radiotherapy, and chemotherapy. Therapy affects not only the patient’s physical condition but also her psychological and social functioning. In this context, nursing care constitutes an integral element of oncological management. It includes educational activities, preparation for treatment, perioperative care, monitoring for potential complications, symptom management, and emotional support. A holistic approach to the patient is essential for maintaining the highest possible quality of life and for effective adaptation to the disease and its consequences.
References
1. Jouya S, Shahabinia Z, Mazidimoradi A, Allahqoli L, Salehiniya H, Lee D-Y. Cervical Cancer Epidemiology: Global Incidence, Mortality, Survival, Risk Factors, and Equity in HPV Screening and Vaccination. J Clin Med. 2026;15(3):1079.
2. Ojha PS, Maste MM, Tubachi S, et al. Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies. VirusDis. 2022;33:132–154.
3. Magiera K, Rybak J, Magiera B, Grabarczyk A, Grabowska-Szczurek M. Rak szyjki macicy – czynniki ryzyka i nowe możliwości profilaktyki w Polsce. Med Srod. 2023;26(3-4):109–13.
4. Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28-37.
5. Rerucha CM, Caro RJ, Wheeler VL. Cervical cancer screening. Am Fam Physician. 2018;97(7):441-448.
6. Selvajothi J, Hewitt M, de Haan A, Ting S, Philpott D, Hayes-Ryan D. Managing women with cervical cancer symptoms: Cervical One-Stop Assessment Clinic. Ir Med J. 2026;119(1):9.
7. Xu M, Cao C, Wu P, Huang X, Ma D. Advances in cervical cancer: current insights and future directions. Cancer Commun. 2025; 45: 77–109.
8. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82
9. Stanisławska J., Janikowska K., Stachowska M., Talarska D., Drozd Gajdus E.,Szewczyczak M.: Ocena wiedzy kobiet w zakresie profilaktyki raka piersi i raka szyjki macicy Probl. Hig. Epidemiol. 2016; 97(1): 38‑44
10. Jach R, Basta A, Kotarski J, Markowska J, Paszkowski T, Dębski R et al. Ten years of anti-HPV vaccinations: what do we know?. Menopause Review/Przegląd Menopauzalny. 2016;15(3):170-175.
11. Kornovski Y, Slavchev S, Kostov S, Ivanova Y, Yordanov A. Etiologia, klasyfikacja, diagnostyka i profilaktyka stanów przedrakowych szyjki macicy. Onkologia w Praktyce Klinicznej - Edukacja. 2021;7(6):387–393.
12. Olthof EP, Bergink-Voorthuis BJ, Wenzel HHB, et al. Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer: a nationwide Dutch cohort study. Insights Imaging. 2024;15(1):36
13. Collettini F, Hamm B. Cervical cancer. In: Forstner R, Cunha TM, Hamm B, editors. MRI and CT of the female pelvis. Medical Radiology. Cham: Springer; 2017
14. Dziukowska J. Diagnostyka obrazowa w onkologii. W: Kułakowski A, Skowrońska-Gardas A, red. Onkologia. Podręcznik dla studentów medycyny. Warszawa: PZWL Wydawnictwo Lekarskie; 2020. s. 42-45
15. Klimek M, Kojs Z. Zasady leczenia raka szyjki macicy. W: Wicherek Ł, Kojs Z, Bręborowicz GH, red. Ginekologia onkologiczna. Warszawa: PZWL Wydawnictwo Lekarskie; 2016. s. 111–126
16. Mustafa WA, Ismail S, Mokhtar FS, Alquran H, Al-Issa Y. Cervical cancer detection techniques: a chronological review. Diagnostics (Basel). 2023;13(10):1763.
17. Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM. Klasyfikacja nowotworów złośliwych. Wyd. 8. Gdańsk: VM Media Sp. z o.o. VM Group Sp. k. (Grupa Via Medica); 2017. 272 s.177-205
18. Piątek S, Bidziński M, Panek G, Wielgoś M, Sobiczewski P. Rak szyjki macicy — ocena zaawansowania choroby według kryteriów FIGO 2018. Ginekologia i Perinatologia Praktyczna. 2019;4(4):149–154.
19. Piątek S. Korekta do artykułu: Rak szyjki macicy — ocena zaawansowania choroby według kryteriów FIGO 2018. Ginekologia i Perinatologia Praktyczna. 2020;5(2):102–103
20. Han L, Chen Y, Zheng A, Chen H. Effect of preoperative cervical conization before hysterectomy on survival and recurrence of patients with cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2023;174:167-174.
21. Li H, Gao R. Efficacy and safety of cervical conization combined with neoadjuvant chemotherapy versus radical trachelectomy in early-stage cervical cancer treatment. Eur J Gynaecol Oncol. 2024;45(4):170-176.
22. Sznurkowski JJ, Bodnar L, Szylberg Ł, Zołciak-Siwińska A, Dańska-Bidzińska A, Klasa-Mazurkiewicz D, et al. The Polish Society of Gynecological Oncology guidelines for the diagnosis and treatment of cervical cancer (v2024.0). J Clin Med. 2024;13(15):4351.
23. Smith ES, Moon AS, O’Hanlon R, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, et al. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020;136(3):533-542.
24. Leziak M., Żak K., Satora M., Szpyra J., Kluz N., and Kułak K., Fertilitysparing treatment of endometrial cancer - is it possible? A case study, „Journal of Education, Health and Sport”, 2022, t.12, pp. 573–578.
25. Manning-Geist BL, et al. Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer. Int J Gynecol Cancer. 2025;35(12):102712.
26. Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, et al. The ESGO/ESTRO/ESP guidelines for the management of cervical cancer. Int J Gynecol Cancer. 2018;28(4):641-655
27. Porras GO, Nogueda JC, Chacón AP. Chemotherapy and molecular therapy in cervical cancer. Reports of Practical Oncology and Radiotherapy. 2018;23(6):533-9.
28. Ryu SY, Kim MH, Nam BH, et al. Is adjuvant chemotherapy effective in cervical cancer treated with radical hysterectomy? Gynecol Oncol. 2017;145(1):136-142
29. Ciechacka M, Pawełko A. Sexual disorders in a 45-year-old patient after hysterectomy in the home. Journal of Education, Health and Sport. 2025;83:64017
30. Wojtas AK, Cygnarowicz A, Sacher K, Zabrojska K, Korotko U, Mandziuk A, Witowska K, Turemka M, Biskupski M, Hosseinnejad N. Pelvic organ prolapse – general overview and latest therapy possibilities. Quality in Sport. 2024;25:56803
31. Wojtas AK, Cygnarowicz A, Sacher K, Zabrojska K, Korotko U, Mandziuk A, Witowska K, Turemka M, Biskupski M, Hosseinnejad N. Pelvic organ prolapse – general overview and latest therapy possibilities. Quality in Sport. 2024;25:56803
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Joanna Ziemiańska, Sara Matusik

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 11
Number of citations: 0